Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CRISPR Therapeutics AG | Chief Medical Officer | Common Shares | 4.41K | $276K | $62.50 | May 24, 2023 | Direct |
CRISPR Therapeutics AG | Chief Medical Officer | Restricted Stock Units | 20.8K | May 23, 2023 | Direct | ||
CRISPR Therapeutics AG | Chief Medical Officer | Stock Option (Right to Buy) | 16.7K | Oct 13, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CRSP | CRISPR Therapeutics AG | Oct 13, 2023 | 1 | $0 | 4 | Oct 17, 2023 | Chief Medical Officer |
CRSP | CRISPR Therapeutics AG | May 23, 2023 | 3 | -$167K | 4 | May 25, 2023 | Chief Medical Officer |
CRSP | CRISPR Therapeutics AG | Mar 10, 2023 | 2 | $0 | 4 | Mar 14, 2023 | Chief Medical Officer |
CRSP | CRISPR Therapeutics AG | Oct 7, 2022 | 1 | $0 | 4 | Oct 12, 2022 | Chief Medical Officer |
CRSP | CRISPR Therapeutics AG | May 23, 2022 | 2 | $0 | 4 | May 24, 2022 | Chief Medical Officer |
CRSP | CRISPR Therapeutics AG | May 23, 2022 | 0 | $0 | 3 | May 23, 2022 | Chief Medical Officer |